| ALUR |
ALLURION TECHNOLOGIES, INC. |
Common Stock, par value $0.0001 per share |
48.1% |
$11.8M |
$3.71M |
5.89M |
+46% |
RTW Investments, LP |
Nov 11, 2025 |
| ALUR |
ALLURION TECHNOLOGIES, INC. |
Common Stock, $0.0001 par value per share |
17.6% |
$452K |
|
1.05M |
0% |
RTW Investments, LP |
Feb 20, 2025 |
| OBIO |
ORCHESTRA BIOMED HOLDINGS, INC. |
Common Stock, par value $0.0001 per share |
15.4% |
$22M |
|
8.31M |
0% |
RTW Investments, LP |
Aug 4, 2025 |
| ESTA |
Establishment Labs Holdings Inc. |
Common Shares, No Par Value |
9.99% |
$97.4M |
|
2.82M |
|
RTW Investments, LP |
Dec 31, 2024 |
| STOK |
Stoke Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
9.99% |
$37.3M |
|
5.31M |
|
RTW Investments, LP |
Dec 31, 2024 |
| NGNE |
Neurogene Inc. |
Common Stock, par value $0.000001 per share |
9.99% |
$16.5M |
|
1.5M |
|
RTW Investments, LP |
Dec 31, 2024 |
| TENX |
Tenax Therapeutics, Inc. |
Common Stock, $0.0001 par value per share |
9.99% |
$2.33M |
|
418K |
|
RTW Investments, LP |
Mar 31, 2025 |
| SABS |
SAB Biotherapeutics, Inc. |
Common Stock, par value $0.0001 per share |
9.99% |
$1.31M |
|
1.02M |
|
RTW Investments, LP |
Dec 31, 2024 |
| TSHA |
TAYSHA GENE THERAPIES, INC. |
Common Stock, par value $0.00001 per share |
9.9% |
$75.5M |
$13.5M |
25.2M |
+21.8% |
RTW Investments, LP |
Jun 30, 2025 |
| VSTM |
Verastem, Inc. |
Common Stock, $0.0001 par value |
9.9% |
$51.1M |
$12.5M |
5.63M |
+32.5% |
RTW Investments, LP |
Jun 30, 2025 |
| CMPS |
COMPASS Pathways plc |
Ordinary Shares, par value GBP 0.008 per share |
9.9% |
$45.6M |
$7.68M |
9.47M |
+20.3% |
RTW Investments, LP |
Jun 30, 2025 |
| MIST |
MILESTONE PHARMACEUTICALS INC. |
Common Shares, no par value per share |
9.9% |
$18.3M |
$7.03M |
9.16M |
+62.3% |
RTW Investments, LP |
Sep 30, 2025 |
| GHRS |
GH Research PLC |
Ordinary shares, nominal value $0.025 per share |
8.9% |
$49.5M |
|
5.5M |
|
RTW Investments, LP |
Mar 31, 2025 |
| RAPT |
Rapt Therapeutics, Inc. |
Common Stock, $0.0001 par value per share |
8.9% |
$10M |
|
11.8M |
|
RTW Investments, LP |
Mar 31, 2025 |
| XNCR |
Xencor Inc |
Common Stock, $0.01 par value |
8.7% |
$73M |
|
6.22M |
|
RTW Investments, LP |
Sep 30, 2025 |
| REPL |
Replimune Group, Inc. |
Common Stock, $0.001 par value |
8.2% |
$26.8M |
|
6.4M |
|
RTW Investments, LP |
Sep 30, 2025 |
| TARS |
Tarsus Pharmaceuticals, Inc. |
Common Stock, par value $0.0001 per share |
8.1% |
$184M |
|
3.42M |
|
RTW Investments, LP |
Jun 30, 2025 |
| XGN |
Exagen Inc. |
Common Stock, par value $0.001 per share |
7.7% |
$16.7M |
|
1.7M |
|
RTW Investments, LP |
Jun 30, 2025 |
| BBNX |
Beta Bionics, Inc. |
Common Stock, $0.0001 par value per share |
7.6% |
$39M |
|
3.3M |
|
RTW Investments, LP |
Mar 31, 2025 |
| AKRO |
Akero Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
7.3% |
$287M |
-$48.2M |
5.87M |
-14.4% |
RTW Investments, LP |
Jun 30, 2025 |
| IMTX |
Immatics N.V. |
Ordinary Shares, nominal value (euro) 0.01 per share |
7.3% |
$75.1M |
$19.4M |
8.82M |
+34.8% |
RTW Investments, LP |
Sep 30, 2025 |
| QURE |
uniQure N.V. |
Ordinary Shares, par value 0.05 euro |
7.2% |
$258M |
-$42.8M |
4.42M |
-14.2% |
RTW Investments, LP |
Sep 30, 2025 |
| ALEC |
Alector, Inc. |
Common Stock, $0.0001 par value |
6.9% |
$20.7M |
|
6.99M |
|
RTW Investments, LP |
Sep 30, 2025 |
| SYRE |
Spyre Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
6.2% |
$44.3M |
|
3.62M |
|
RTW Investments, LP |
Dec 31, 2024 |
| APGE |
Apogee Therapeutics, Inc. |
Common Stock, $0.00001 par value per share |
6% |
$86.2M |
|
2.71M |
|
RTW Investments, LP |
Dec 31, 2024 |
| AQST |
Aquestive Therapeutics, Inc. |
Common Stock, $0.001 par value |
5.2% |
$34.9M |
|
6.25M |
|
RTW Investments, LP |
Sep 30, 2025 |
| ORKA |
Oruka Therapeutics, Inc. |
Common Stock, par value $0.001 per share |
5.2% |
$18.3M |
|
1.95M |
|
RTW Investments, LP |
Mar 31, 2025 |
| SAGE |
Sage Therapeutics, Inc. |
Common Stock, par value $0.0001 per share |
4.9% |
$20.7M |
|
3M |
|
RTW Investments, LP |
Dec 31, 2024 |
| ACAD |
ACADIA PHARMACEUTICALS INC. |
Common Stock, $0.0001 par value |
4.2% |
$152M |
-$33.3M |
7.14M |
-17.9% |
RTW Investments, LP |
Sep 30, 2025 |
| RNA |
Avidity Biosciences, Inc. |
Common Stock, par value $0.0001 per share |
3.1% |
$204M |
|
4.69M |
|
RTW Investments, LP |
Oct 27, 2025 |
| AXSM |
Axsome Therapeutics, Inc. |
Common Stock, $0.0001 par value per share |
3.1% |
$177M |
-$164M |
1.52M |
-48.1% |
RTW Investments, LP |
Jun 30, 2025 |
| MRUS |
Merus N.V. |
Common Shares, nominal value (euro) 0.09 per share |
2.7% |
$191M |
|
2.03M |
|
RTW Investments, LP |
Sep 30, 2025 |
| EPIX |
ESSA Pharma Inc. |
Common Shares, no par value |
2.5% |
$1.69M |
|
1.11M |
|
RTW Investments, LP |
Dec 31, 2024 |
| ZLAB |
Zai Lab Limited |
Ordinary Shares, par value $0.000006 per share |
2.1% |
$777M |
-$1.1B |
22.9M |
-58.6% |
RTW Investments, LP |
Sep 30, 2025 |
| DYN |
Dyne Therapeutics, Inc. |
Common Stock, $0.0001 par value per share |
1.5% |
$12.8M |
-$26.6M |
1.69M |
-67.6% |
RTW Investments, LP |
Mar 31, 2025 |
| ETNB |
89bio, Inc. |
Common Stock, par value $0.001 per share |
1.3% |
$14.3M |
|
1.97M |
|
RTW Investments, LP |
Mar 31, 2025 |
| IMUX |
Immunic, Inc. |
Common Stock, par value $0.0001 per share |
1.1% |
$924K |
|
1.03M |
|
RTW Investments, LP |
Mar 31, 2025 |
| CUTRQ |
Cutera, Inc. |
Common Stock, $0.001 par value |
0% |
$0 |
|
0 |
|
RTW Investments, LP |
Dec 31, 2024 |
| PEPG |
PepGen Inc. |
Common Stock, $0.0001 par value per share |
0% |
$0 |
-$3.61M |
0 |
-100% |
RTW Investments, LP |
Mar 31, 2025 |
| GERN |
Geron Corporation |
Common Stock, $0.001 par value |
0% |
$0 |
|
0 |
|
RTW Investments, LP |
Dec 31, 2024 |
| CRGX |
CARGO THERAPEUTICS, INC. |
Common stock, par value $0.001 per share |
0% |
$0 |
-$13.7M |
0 |
-100% |
RTW Investments, LP |
Sep 30, 2025 |